ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 83 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $5,874,000 | -39.9% | 707,746 | 0.0% | 0.78% | +27.2% |
| Q3 2018 | $9,767,000 | +182.9% | 707,746 | +62.9% | 0.62% | +177.0% |
| Q2 2018 | $3,453,000 | +42.1% | 434,344 | +34.0% | 0.22% | +40.5% |
| Q1 2018 | $2,430,000 | +117.4% | 324,019 | +97.1% | 0.16% | +4.6% |
| Q4 2017 | $1,118,000 | – | 164,384 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,155,300 | $4,621,000 | 2.77% |
| Knoll Capital Management, LLC | 759,405 | $3,038,000 | 1.67% |
| ACUTA CAPITAL PARTNERS, LLC | 500,000 | $2,000,000 | 0.84% |
| Perceptive Advisors | 19,807,758 | $79,232,000 | 0.61% |
| Mesirow Financial Investment Management, Inc. | 48,711 | $195,000 | 0.56% |
| Ghost Tree Capital, LLC | 300,000 | $1,200,000 | 0.43% |
| Stonepine Capital Management, LLC | 200,000 | $800,000 | 0.37% |
| APOGEM CAPITAL LLC | 86,730 | $347,000 | 0.23% |
| JOHNSON & JOHNSON | 394,834 | $1,579,000 | 0.18% |
| Affinity Asset Advisors, LLC | 100,759 | $403,000 | 0.15% |